Accordingly, p130Cas is overexpressed in human triple-negative breast cancer (Tornillo et al., 2013; Table 1), implying that the increased expression of p130Cas may be a priming event for the onset of basal-like breast cancer. This evidence concerns the gene BCAR1 and breast cancer.